eISSN 2384-1109
Open Access, Peer-reviewed
    J Korean Soc Magn Reson Med. 2013 Sep;17(3):232-238. Korean.
    Published online Sep 30, 2013.
    https://doi.org/10.13104/jksmrm.2013.17.3.232
    Copyright © 2013 Journal of the Korean Society of Magnetic Resonance in Medicine
    Original Article

    Added Value of Magnetic Resonance Imaging in Staging of Malignant Pleural Mesothelioma

    Eunsol Lee, Eun Jin Chae, Sunji Kang, Yoo Kyeong Yeom, Hyun Joo Lee, Jong Chun Park, So Youn Shin, Yoon Young Choi, Joon Ho Choi and Kyung-Hyun Do
      • Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Korea.
    • Corresponding author: Eun Jin Chae, M.D. Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel. 82-2-3010-4355, Fax. 82-2-476-0090, Email: ejinchae@gmail.com
    Received August 20, 2013; Revised September 09, 2013; Accepted September 17, 2013.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Abstract

    Purpose

    We investigated the possible added value of magnetic resonance imaging (MR) in staging of malignant pleural mesothelioma (MPM) compared to computed tomography (CT).

    Materials and Methods

    We retrospectively enrolled 20 patients (M;F = 14:6; mean age, 53.5 yrs) who diagnosed as MPM by histology and underwent CT and MR at initial evaluation from Jan 1997 to Dec 2012. Two radiologists performed clinical staging by using CT alone or MR alone in consensus. In patients underwent surgery (n = 13), we evaluated the diagnostic accuracy of CT and MR in terms of staging compared to surgical staging. In all patients, we compared clinical staging of CT only and CT with MR.

    Results

    The diagnostic accuracy for T staging of CT only was 23.1% (3/13) and that of combined CT and MR was 38.5% (5/13), respectively. Among 13 patients underwent surgery, surgical stage was higher than combined CT and MR stage in 5 patients, but lower in 3 patients. CT only and combined CT and MR agreed in 85.0% (17/20). In cases of disagree (15.0%, 3/20), combined CT and MR showed higher stage than CT only.

    Conclusion

    Combined CT and MR increases the diagnostic accuracy in staging of MPM compared to CT only and is important in determining the appropriate treatment in patients being considered for surgery.

    Keywords
    Malignant pleural mesothelioma; Magnetic resonance imaging (MR); TNM staging

    Figures

    Fig. 1
    Differences between clinical T stage and corrected surgical T stage in patients with available surgical stage.

    Fig. 2
    A representative case of upstaging by MR compared to surgical stage.

    a. A CT image shows circumferential pleural thickening involving visceral and parietal pleura. Areas of obliteration of extrapleural fat probably over the expected line of endothoracic fascia suggest chest wall invasion (T4) (arrows).

    b. Gadolinium-enhanced T1-weighted MR image shows some indentation of chest wall by the pleural mass suggesting chest wall invasion (T4) (arrows). However, patient underwent pleuropneumonectomy and surgical and histologic findings revealed no evidence of chest wall invasion (T2).

    Fig. 3
    Differences between clinical stage by CT only and CT and MR.

    Fig. 4
    A representative case of upstaging by MR compared to CT.

    a. A CT image shows pleural effusion with diffuse pleural thickening. Soft tissue density lesions are suspicious in intercostal spaces in the lower portion of hemithorax, however chest wall invasion is not clear.

    b. Gadolinium-enhanced, 3-dimensional, gradient recalled echo sequence MR image clearly shows enhancing soft tissue lesions in the intercostal spaces suggesting diffuse chest wall invasion (T4) (arrow).

    Tables

    Table 1
    Clinical Characteristics Including Clinical and Surgical Staging of Subjects

    References

      1. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1–14.
      1. Teta MJ, Mink PJ, Lau E, Sceurman BK, Foster ED. US mesothelioma patterns 1973-2002: indicators of change and insights into background rates. Eur J Cancer Prev 2008;17:525–534.
      1. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004;159:107–112.
      1. Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 2011;89:716–724.
      1. Cao C, Tian DH, Pataky KA, Yan TD. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer 2013;81:319–327.
      1. Erasmus JJ, Truong MT, Smythe WR, et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 2005;129:1364–1370.
      1. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479–495.
      1. Martino D, Pass HI. Integration of multimodality approaches in the management of malignant pleural mesothelioma. Clin Lung Cancer 2004;5:290–298.
      1. Neumann V, Loseke S, Nowak D, Herth FJ, Tannapfel A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int 2013;110:319–326.
      1. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54–63.
      1. Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 2013;145:909–910.
      1. Nowak AK. CT, RECIST, and malignant pleural mesothelioma. Lung Cancer 2005;49 Suppl 1:S37–S40.
      1. Patz EF Jr, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992;159:961–966.
      1. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999;172:1039–1047.
      1. Wang ZJ, Reddy GP, Gotway MB, et al. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics 2004;24:105–119.
      1. Boiselle PM, Patz EF Jr, Vining DJ, Weissleder R, Shepard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. Radiographics 1998;18:1061–1069.
      1. Karabulut N, Martin DR, Yang M, Tallaksen RJ. MR imaging of the chest using a contrast-enhanced breath-hold modified three-dimensional gradient-echo technique: comparison with two-dimensional gradient-echo technique and multidetector CT. AJR Am J Roentgenol 2002;179:1225–1233.
      1. Hintze C, Dinkel J, Biederer J, Heussel CP, Puderbach M. New procedures. Comprehensive staging of lung cancer by MRI. Radiologe 2010;50:699–705.
      1. Kajiwara N, Akata S, Uchida O, et al. Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion. Lung Cancer 2010;69:203–208.
      1. Plathow C, Staab A, Schmaehl A, et al. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results. Invest Radiol 2008;43:737–744.
      1. Zahid I, Sharif S, Routledge T, Scarci M. What is the best way to diagnose and stage malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg 2011;12:254–259.
      1. Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995;108:1122–1128.
      1. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763–772.
      1. Datta A, Smith R, Fiorentino F, Treasure T. Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position. Thorax. 2013
        Epub.
      1. Gill RR. Imaging of mesothelioma. Recent Results Cancer Res 2011;189:27–43.
      1. Gill RR, Gerbaudo VH, Jacobson FL, et al. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am 2008;16:319–339.
      1. Donmez FY, Yekeler E, Saeidi V, Tunaci A, Tunaci M, Acunas G. Dynamic contrast enhancement patterns of solitary pulmonary nodules on 3D gradient-recalled echo MRI. AJR Am J Roentgenol 2007;189:1380–1386.
      1. Lee VS, Lavelle MT, Krinsky GA, Rofsky NM. Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin N Am 2001;9:697–716.
      1. Weber U, Lambert RG, Rufibach K, et al. Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study. Arthritis Res Ther 2012;14:R3.
    MeSH Terms
    Consensus
    Humans
    Magnetic Resonance Imaging
    Magnetic Resonance Spectroscopy
    Magnetics
    Magnets
    Mesothelioma
    Neoplasm Staging
    Retrospective Studies
    Metrics
    Share
    Figures
    slide
    slide
    slide
    slide

    1 / 4

    Tables
    slide

    1 / 1

    PERMALINK